← Jiangsu Sidike New Materials Sci Te overview

Jiangsu Sidike New Materials Sci Te vs Axalta Coating Systems: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Jiangsu Sidike New Materials Sci Te (300806.CS)

Q3 202624 Jul – 23 Sep 2026

▲3

Sidike's profit jumps and it bets big on MLCC materials

First-half profit up 82% Sidike's first-half 2026 net profit rose 82.38% to 46.0 million yuan, with second-quarter profit up 102% from the first quarter. Stronger earnings show the business is growing and can support the stock price.
This is the core fundamental improvement that makes the stock more valuable.
Cash flow and debt raise caution The same interim report showed operating cash flow was negative 72.8 million yuan, a sharp reversal from last year, and the debt ratio was 67.51%. Weak cash generation and high borrowing are a real risk that can weigh on the stock.
It is the main counterweight to the good profit news and gives a fair picture.
MLCC boom lifts demand MLCC prices have surged since June 2026, with high-capacitance parts up 60–80%, and overseas leaders reported record profits and orders. Sidike is a top gainer in the MLCC concept, so the industry upcycle supports its sales and stock price.
It explains the strong industry demand behind Sidike's products and share-price gains.
1.65 billion yuan expansion Sidike plans to invest 1.652 billion yuan in a new plant to make 103,000 tonnes of high-end BOPET base film, mainly for MLCC manufacturing. This big capacity bet aims to capture growing demand, though it needs shareholder and government approvals.
It is the largest new capital commitment and directly ties Sidike to the MLCC supply chain.

August 202624 Jul – 23 Sep 2026

▲3

Sidike's profit jumps and it bets big on MLCC materials

First-half profit up 82% Sidike's first-half 2026 net profit rose 82.38% to 46.0 million yuan, with second-quarter profit up 102% from the first quarter. Stronger earnings show the business is growing and can support the stock price.
This is the core fundamental improvement that makes the stock more valuable.
Cash flow and debt raise caution The same interim report showed operating cash flow was negative 72.8 million yuan, a sharp reversal from last year, and the debt ratio was 67.51%. Weak cash generation and high borrowing are a real risk that can weigh on the stock.
It is the main counterweight to the good profit news and gives a fair picture.
MLCC boom lifts demand MLCC prices have surged since June 2026, with high-capacitance parts up 60–80%, and overseas leaders reported record profits and orders. Sidike is a top gainer in the MLCC concept, so the industry upcycle supports its sales and stock price.
It explains the strong industry demand behind Sidike's products and share-price gains.
1.65 billion yuan expansion Sidike plans to invest 1.652 billion yuan in a new plant to make 103,000 tonnes of high-end BOPET base film, mainly for MLCC manufacturing. This big capacity bet aims to capture growing demand, though it needs shareholder and government approvals.
It is the largest new capital commitment and directly ties Sidike to the MLCC supply chain.

Latest24 Jul – 23 Sep 2026

▲3

Sidike's profit jumps and it bets big on MLCC materials

First-half profit up 82% Sidike's first-half 2026 net profit rose 82.38% to 46.0 million yuan, with second-quarter profit up 102% from the first quarter. Stronger earnings show the business is growing and can support the stock price.
This is the core fundamental improvement that makes the stock more valuable.
Cash flow and debt raise caution The same interim report showed operating cash flow was negative 72.8 million yuan, a sharp reversal from last year, and the debt ratio was 67.51%. Weak cash generation and high borrowing are a real risk that can weigh on the stock.
It is the main counterweight to the good profit news and gives a fair picture.
MLCC boom lifts demand MLCC prices have surged since June 2026, with high-capacitance parts up 60–80%, and overseas leaders reported record profits and orders. Sidike is a top gainer in the MLCC concept, so the industry upcycle supports its sales and stock price.
It explains the strong industry demand behind Sidike's products and share-price gains.
1.65 billion yuan expansion Sidike plans to invest 1.652 billion yuan in a new plant to make 103,000 tonnes of high-end BOPET base film, mainly for MLCC manufacturing. This big capacity bet aims to capture growing demand, though it needs shareholder and government approvals.
It is the largest new capital commitment and directly ties Sidike to the MLCC supply chain.

Axalta Coating Systems Ltd (AXTA)

Q3 202615 Jul – 9 Oct 2026

▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.
This is the biggest new force: the merger's key regulatory hurdle is being cleared.
Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.
The quarter's results are the core fundamental driver behind the shares.
Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.
These steps reduce deal risk and show the partner is financially healthy.
Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.
This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

August 202615 Jul – 9 Oct 2026

▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.
This is the biggest new force: the merger's key regulatory hurdle is being cleared.
Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.
The quarter's results are the core fundamental driver behind the shares.
Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.
These steps reduce deal risk and show the partner is financially healthy.
Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.
This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

Latest15 Jul – 9 Oct 2026

▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.
This is the biggest new force: the merger's key regulatory hurdle is being cleared.
Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.
The quarter's results are the core fundamental driver behind the shares.
Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.
These steps reduce deal risk and show the partner is financially healthy.
Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.
This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.